State Street’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,439,140
Closed -$7.41M 4335
2024
Q4
$7.41M Buy
2,439,140
+5,177
+0.2% +$15.7K ﹤0.01% 2778
2024
Q3
$12.6M Buy
2,433,963
+150,323
+7% +$780K ﹤0.01% 2473
2024
Q2
$5.87M Sell
2,283,640
-75,137
-3% -$193K ﹤0.01% 2850
2024
Q1
$11.6M Sell
2,358,777
-162,916
-6% -$802K ﹤0.01% 2492
2023
Q4
$22.2M Buy
2,521,693
+188,585
+8% +$1.66M ﹤0.01% 2155
2023
Q3
$26.8M Buy
2,333,108
+282,326
+14% +$3.24M ﹤0.01% 1996
2023
Q2
$51.9M Buy
2,050,782
+103,019
+5% +$2.61M ﹤0.01% 1655
2023
Q1
$62.7M Sell
1,947,763
-101,832
-5% -$3.28M ﹤0.01% 1491
2022
Q4
$37.8M Buy
2,049,595
+433,142
+27% +$8M ﹤0.01% 1830
2022
Q3
$43.6M Sell
1,616,453
-163,340
-9% -$4.41M ﹤0.01% 1687
2022
Q2
$24.6M Buy
1,779,793
+238,356
+15% +$3.29M ﹤0.01% 2103
2022
Q1
$30.1M Sell
1,541,437
-25,409
-2% -$495K ﹤0.01% 2105
2021
Q4
$25.6M Buy
1,566,846
+59,008
+4% +$963K ﹤0.01% 2292
2021
Q3
$42M Buy
1,507,838
+71,394
+5% +$1.99M ﹤0.01% 1936
2021
Q2
$42.6M Buy
1,436,444
+85,278
+6% +$2.53M ﹤0.01% 1965
2021
Q1
$37.8M Sell
1,351,166
-119,110
-8% -$3.33M ﹤0.01% 1951
2020
Q4
$41.7M Buy
1,470,276
+129,870
+10% +$3.68M ﹤0.01% 1751
2020
Q3
$33.7M Sell
1,340,406
-9,674
-0.7% -$243K ﹤0.01% 1719
2020
Q2
$33M Buy
1,350,080
+191,025
+16% +$4.66M ﹤0.01% 1711
2020
Q1
$17.2M Buy
1,159,055
+103,665
+10% +$1.53M ﹤0.01% 1936
2019
Q4
$17.1M Buy
1,055,390
+33,269
+3% +$540K ﹤0.01% 2250
2019
Q3
$13.3M Buy
1,022,121
+83,049
+9% +$1.08M ﹤0.01% 2321
2019
Q2
$12.2M Buy
939,072
+125,629
+15% +$1.63M ﹤0.01% 2402
2019
Q1
$12.8M Buy
813,443
+137,221
+20% +$2.16M ﹤0.01% 2333
2018
Q4
$13.6M Sell
676,222
-43,924
-6% -$884K ﹤0.01% 2254
2018
Q3
$17.9M Buy
720,146
+50,821
+8% +$1.26M ﹤0.01% 2251
2018
Q2
$18.4M Buy
669,325
+76,415
+13% +$2.1M ﹤0.01% 2189
2018
Q1
$18.3M Buy
592,910
+131,550
+29% +$4.05M ﹤0.01% 2115
2017
Q4
$16.5M Sell
461,360
-4,737
-1% -$169K ﹤0.01% 2180
2017
Q3
$12.8M Buy
466,097
+13,607
+3% +$375K ﹤0.01% 2313
2017
Q2
$11.9M Buy
452,490
+2,637
+0.6% +$69.6K ﹤0.01% 2309
2017
Q1
$9.36M Buy
449,853
+124,705
+38% +$2.59M ﹤0.01% 2403
2016
Q4
$6.73M Buy
325,148
+17,410
+6% +$360K ﹤0.01% 2519
2016
Q3
$4.99M Sell
307,738
-121,744
-28% -$1.97M ﹤0.01% 2566
2016
Q2
$5.84M Sell
429,482
-97,834
-19% -$1.33M ﹤0.01% 2505
2016
Q1
$9.21M Buy
527,316
+138,520
+36% +$2.42M ﹤0.01% 2224
2015
Q4
$13.3M Buy
388,796
+162,690
+72% +$5.56M ﹤0.01% 2015
2015
Q3
$6.73M Buy
226,106
+32,885
+17% +$979K ﹤0.01% 2378
2015
Q2
$6.19M Buy
193,221
+81,796
+73% +$2.62M ﹤0.01% 2522
2015
Q1
$2.31M Buy
111,425
+7,683
+7% +$159K ﹤0.01% 2967
2014
Q4
$1.76M Buy
103,742
+4,883
+5% +$82.7K ﹤0.01% 3092
2014
Q3
$1.91M Buy
98,859
+7,630
+8% +$148K ﹤0.01% 3036
2014
Q2
$3.1M Buy
91,229
+25,734
+39% +$875K ﹤0.01% 2848
2014
Q1
$2.06M Buy
+65,495
New +$2.06M ﹤0.01% 3045